Core Scientific, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.9% | +14.3% | -6.5% | +21.1% | +73.4% | +1.7% | +21.7% | +16.1% | +2.3% | +30.8% | +71.3% | |
| – | -28.0% | +47.7% | -17.8% | +135.7% | +225.3% | -7.8% | +20.6% | +5.6% | -15.6% | +62.5% | +68.0% | |
| – | -21.2% | +94.7% | -2.0% | +163.2% | +230.5% | -16.5% | -16.7% | -22.0% | -31.3% | +222.8% | +76.1% | |
| – | -21.8% | +94.7% | -2.0% | +163.2% | +230.5% | -16.5% | -16.7% | -22.0% | -31.3% | +222.8% | +76.1% | |
| – | +256.3% | -84.5% | +322.4% | +33.5% | -83.6% | -0.7% | +24,521.1% | – | – | -6.4% | +21.6% | |
| – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | -8.2% | -4.9% | – | – | – | – | – | – | – | – | – | |
| – | +16.4% | -13.5% | +62.9% | -10.5% | +46.5% | -25.3% | +68.4% | +12.5% | -3.3% | +32.2% | +75.5% | |
| – | +56.2% | -71.7% | -45.8% | +2.3% | +75.9% | +45.3% | +187.8% | +19.0% | +16.7% | +240.6% | +2.9% | |
| – | -2.8% | -79.9% | -8.5% | +4.9% | +0.5% | -2.1% | -54.2% | – | – | – | – | |
| – | +239.9% | -89.6% | -47.5% | -23.4% | +196.2% | -67.2% | +3,298.5% | -1.3% | -40.6% | +73.6% | -48.7% | |
| – | +0.7% | -18.6% | -5.4% | -9.9% | +126.3% | -0.2% | -1.3% | +0.1% | +0.1% | +0.1% | +304.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | -26.6% | +1.8% | +1.7% | +4.7% | +18.7% | -12.5% | +0.2% | -0.1% | +1.4% | +0.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.